{"id":22214,"date":"2022-12-29T11:50:54","date_gmt":"2022-12-29T19:50:54","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=22214"},"modified":"2024-07-09T15:28:18","modified_gmt":"2024-07-09T22:28:18","slug":"xospata-gilteritinib","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/","title":{"rendered":"Xospata\uff08\u5409\u5229\u66ff\u5c3c\uff09"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">\u764c\u75c7\u662f\u4e16\u754c\u4e0a\u6700\u81f4\u547d\u7684\u5065\u5eb7\u95ee\u9898\u4e4b\u4e00\u3002\u5b83\u6709\u591a\u79cd\u4e0d\u540c\u7684\u5f62\u5f0f\uff0c\u5176\u4e2d\u4e00\u79cd\u5c31\u662f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5 (AML)\u3002AML \u662f\u4e00\u79cd\u8840\u764c\uff0c\u8d77\u6e90\u4e8e\u9aa8\u9ad3\u3002\u5982\u679c\u4e0d\u53ca\u65f6\u6cbb\u7597\uff0c\u8fd9\u79cd\u764c\u75c7\u901a\u5e38\u4f1a\u8fc5\u901f\u6076\u5316\u3002AML \u4e5f\u79f0\u4e3a\u6025\u6027\u975e\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\u6216\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u3002&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-a2f3290f9184eb658f42e56738457f7e\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u83b7\u5f97\u5171\u4ed8\u989d\u63f4\u52a9\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\t\u4e0e\u4e13\u5bb6\u4ea4\u8c08\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">\u9aa8\u9ad3\u662f\u4eba\u4f53\u9aa8\u9abc\u7684\u91cd\u8981\u7ec4\u6210\u90e8\u5206\uff0c\u56e0\u4e3a\u5b83\u8d1f\u8d23\u751f\u6210\u4eba\u4f53\u5faa\u73af\u7cfb\u7edf\u4e2d\u7684\u767d\u7ec6\u80de\u3001\u7ea2\u7ec6\u80de\u548c\u8840\u5c0f\u677f\u3002\u5f53\u9aa8\u9ad3\u53d7\u5230\u8fd9\u79cd\u764c\u75c7\u7684\u5f71\u54cd\u65f6\uff0c\u5b83\u4f1a\u5f00\u59cb\u4ea7\u751f\u88ab\u79f0\u4e3a\u539f\u59cb\u7ec6\u80de\u7684\u5f02\u5e38\u7ec6\u80de\u3002<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u6839\u636e\u6700\u8fd1\u7684\u7814\u7a76\uff0cAML \u662f\u5f71\u54cd\u6210\u5e74\u4eba\u7684\u6700\u5e38\u89c1\u767d\u8840\u75c5\u7c7b\u578b\u3002\u5728\u7f8e\u56fd\uff0c\u5927\u7ea6 <\/span><a href=\"https:\/\/www.cancer.org\/cancer\/acute-myeloid-leukemia\/about\/key-statistics.html\"><span style=\"font-weight: 400;\">2\u4e07\u4eba<\/span><\/a><span style=\"font-weight: 400;\"> \u6bcf\u5e74\u90fd\u4f1a\u60a3\u4e0a\u8fd9\u79cd\u764c\u75c7\uff0c\u867d\u7136\u5b83\u5728\u6210\u5e74\u4eba\u4e2d\u5f88\u5e38\u89c1\uff0c\u4f46\u4e5f\u5f71\u54cd\u5230\u5e74\u8f7b\u4eba\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">AML \u7b49\u764c\u75c7\u53ef\u80fd\u662f\u7531\u80bf\u7624\u6291\u5236\u57fa\u56e0\u5173\u95ed\u6216\u81f4\u764c\u57fa\u56e0\u5f00\u542f\u7684\u7a81\u53d8\u5f15\u8d77\u7684\u3002\u4f8b\u5982\uff0cAML \u7ec6\u80de\u4e2d\u53ef\u80fd\u53d1\u751f c-KIT\u3001FLT3 \u548c RAS \u7b49\u57fa\u56e0\u7684\u6539\u53d8\u3002\u8fd9\u4e9b\u6539\u53d8\u53ef\u80fd\u5bfc\u81f4\u9aa8\u9ad3\u7ec6\u80de\u5931\u63a7\u751f\u957f\u6216\u505c\u6b62\u6b63\u5e38\u6210\u719f\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Xospata \u662f\u6cbb\u7597 AML \u7684\u6700\u4f73\u9009\u62e9\u4e4b\u4e00\u3002\u672c\u6587\u5c06\u63a2\u8ba8\u8be5\u836f\u7269\u7684\u836f\u6548\u3001\u5408\u9002\u7684\u5242\u91cf\u4ee5\u53ca\u526f\u4f5c\u7528\u3002&nbsp;<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"\u5207\u6362\u76ee\u5f55\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">\u5207\u6362<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#What_Is_Xospata\" >Xospata \u662f\u4ec0\u4e48\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#Approval_and_Efficacy\" >\u6279\u51c6\u548c\u6548\u529b<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#Dosage\" >\u5242\u91cf<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#Side_Effects_of_Xospata\" >Xospata\u7684\u526f\u4f5c\u7528<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#Mild_and_Common_Side_Effects\" >\u8f7b\u5fae\u548c\u5e38\u89c1\u7684\u526f\u4f5c\u7528<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#Serious_Side_Effects\" >\u4e25\u91cd\u7684\u526f\u4f5c\u7528<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#Cost\" >\u6210\u672c<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Xospata\"><\/span>Xospata \u662f\u4ec0\u4e48\uff1f<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Xospata \u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u6210\u4eba\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5 (AML) \u7684\u836f\u7269\uff0c\u8be5\u75c5\u60a3\u8005\u643a\u5e26\u4e00\u79cd\u540d\u4e3a FMS \u6837\u916a\u6c28\u9178\u6fc0\u9176 3 \u7a81\u53d8 (FLT-3) \u7684\u7a81\u53d8\u3002\u8fd9\u79cd\u7a81\u53d8\u4f1a\u5bfc\u81f4\u767d\u8840\u75c5\u7ec6\u80de\u5feb\u901f\u751f\u957f\u53d1\u80b2\uff0c\u4ece\u800c\u51cf\u5c11\u5065\u5eb7\u8840\u7ec6\u80de\u7684\u4ea7\u751f\u673a\u4f1a\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u8be5\u7a81\u53d8\u4e5f\u662fAML\u60a3\u8005\u4e2d\u6700\u5e38\u89c1\u7684\u7a81\u53d8\u7c7b\u578b\u3002 <\/span><a href=\"https:\/\/ashpublications.org\/blood\/article\/100\/7\/2393\/106192\/Studies-of-FLT3-mutations-in-paired-presentation#:~:text=FLT3%20mutations%2C%20either%20internal%20tandem,with%20an%20increased%20relapse%20rate.\"><span style=\"font-weight: 400;\">\u6bcf\u4e09\u4e2a\u4eba\u4e2d\u5c31\u6709\u4e00\u4e2a<\/span><\/a><span style=\"font-weight: 400;\"> \u60a3\u6709 AML \u7684\u60a3\u8005\u6709 FLT-3 \u7a81\u53d8\u3002Xospata \u7684\u7ed9\u836f\u662f\u5728\u60a3\u8005\u51fa\u73b0 <\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-treatment-adult-patients-who-have-relapsed-or-refractory-acute-myeloid-leukemia-aml\"><span style=\"font-weight: 400;\">\u5df2\u63a5\u53d7\u6d4b\u8bd5<\/span><\/a><span style=\"font-weight: 400;\"> \u662f\u5426\u5b58\u5728\u7a81\u53d8\u57fa\u56e0\uff0c\u4ee5\u53ca\u5176\u4ed6\u5f62\u5f0f\u7684\u6cbb\u7597\u662f\u5426\u6709\u6548\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Xospata \u662f\u6d3b\u6027\u6210\u5206\u4e3a\u5409\u5229\u66ff\u5c3c (gilteritinib) \u7684\u836f\u7269\u7684\u5546\u54c1\u540d\u3002\u5409\u5229\u66ff\u5c3c\u5c5e\u4e8e\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242 (TKI)\u3002\u8fd9\u7c7b\u6291\u5236\u5242\u9776\u5411\u5e76\u653b\u51fb\u764c\u7ec6\u80de\u6216\u5f02\u5e38\u7ec6\u80de\u3002Xospata \u5c24\u5176\u6291\u5236 FMS \u6837\u916a\u6c28\u9178\u6fc0\u9176 3 (FLT-3)\u3002\u8be5\u836f\u7269\u4e3a 40 \u6beb\u514b\u7247\u5242\uff0c\u9700\u6574\u7247\u670d\u7528\u3002\u8bf7\u52ff\u538b\u788e\u3001\u63b0\u5f00\u6216\u5480\u56bc\u836f\u7247\u3002&nbsp;&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Approval_and_Efficacy\"><\/span>\u6279\u51c6\u548c\u6548\u529b<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u7ba1\u7406\u5c40 (FDA) <\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-treatment-adult-patients-who-have-relapsed-or-refractory-acute-myeloid-leukemia-aml\"><span style=\"font-weight: 400;\">\u5f97\u5230\u6b63\u5f0f\u8ba4\u53ef\u7684<\/span><\/a><span style=\"font-weight: 400;\"> Xospata \u81ea 2018 \u5e74\u4ee5\u6765\u4e00\u76f4\u5904\u4e8e\u7814\u53d1\u9636\u6bb5\u3002\u6b64\u524d\uff0c\u5927\u91cf\u7814\u7a76\u8868\u660e Xospata \u53ef\u6709\u6548\u6cbb\u7597 AML FLT-3 \u7a81\u53d8\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u5728 <\/span><a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=b5ff59aa-9c0d-49a8-9053-1f179b482383\"><span style=\"font-weight: 400;\">\u5176\u4e2d\u4e00\u9879\u7814\u7a76<\/span><\/a><span style=\"font-weight: 400;\">\uff0c\u5c06Xospata\u7684\u7597\u6548\u4e0e\u5176\u4ed6\u53ef\u7528\u7684AML\u6cbb\u7597\u65b9\u6848\u8fdb\u884c\u4e86\u6bd4\u8f83\u3002\u8be5\u7814\u7a76\u7684\u76ee\u7684\u662f\u786e\u5b9a\u54ea\u79cd\u6cbb\u7597\u65b9\u6848\u6709\u52a9\u4e8e\u5b9e\u73b0\u764c\u75c7\u5b8c\u5168\u7f13\u89e3\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u7814\u7a76\u7ed3\u675f\u65f6\u53d1\u73b0\uff0c\u4f7f\u7528 Xospata \u7684\u60a3\u8005\u4e2d\uff0c\u6709 14.2% \u7684\u4eba\u8fbe\u5230\u4e86\u7f13\u89e3\uff0c\u800c\u4f7f\u7528\u5176\u4ed6\u6cbb\u7597\u65b9\u6848\u7684\u60a3\u8005\u4e2d\uff0c\u53ea\u6709 10.5% \u7684\u4eba\u8fbe\u5230\u4e86\u7f13\u89e3\uff0c\u4f8b\u5982 <a href=\"https:\/\/ameripharmaspecialty.com\/zh\/oral-chemotherapy-cancer-drugs\/\">\u5316\u7597<\/a>\u4e0e\u63a5\u53d7\u5316\u7597\u7684\u60a3\u8005\u76f8\u6bd4\uff0c\u4f7f\u7528 Xospata \u7684\u53c2\u4e0e\u8005\u7684\u7f13\u89e3\u671f\u66f4\u957f\uff0c\u751f\u5b58\u671f\u4e5f\u66f4\u957f\u3002\u7f13\u89e3\u671f\u5dee\u5f02\u4e3a 13 \u4e2a\u6708\uff0c\u800c\u751f\u5b58\u671f\u5dee\u5f02\u4e3a 4 \u4e2a\u6708\u3002&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-42b1b8aaa11ef29c253ce227a9ff4a10\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u4e0e\u4e13\u5bb6\u8ba8\u8bba\u5171\u4ed8\u989d\u63f4\u52a9\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">\u5b89\u6392\u54a8\u8be2<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dosage\"><\/span>\u5242\u91cf<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"290\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata.jpg\" alt=\"Patient taking Xospata\" class=\"wp-image-22215\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata-300x207.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata-86x59.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata-167x115.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata-280x193.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/patient-taking-xospata-370x255.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">\u4e0d\u540c\u4eba\u7fa4\u7684 Xospata \u5242\u91cf\u6709\u6240\u4e0d\u540c\u3002\u8fd9\u662f\u56e0\u4e3a\u51b3\u5b9a\u786e\u5207\u5242\u91cf\u7684\u56e0\u7d20\u6709\u5f88\u591a\uff0c\u5176\u4e2d\u5305\u62ec\u6f5c\u5728\u75be\u75c5\u548c AML \u7684\u4e25\u91cd\u7a0b\u5ea6\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u5927\u591a\u6570\u60c5\u51b5\u4e0b\uff0c\u4f60\u4f1a\u4ece\u4f4e\u5242\u91cf\u5f00\u59cb\uff0c\u533b\u751f\u4f1a\u6839\u636e\u4f60\u7684\u53cd\u5e94\u7387\u8c03\u6574\u5242\u91cf\u3002\u76ee\u6807\u662f\u8ba9\u4f60\u4ece\u6700\u5c0f\u5242\u91cf\u5f00\u59cb\uff0c\u8fbe\u5230\u6700\u7406\u60f3\u7684\u6548\u679c\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u5982\u679c\u60a8\u5f00\u59cb\u6ce8\u610f\u5230\u4efb\u4f55\u526f\u4f5c\u7528\uff0c\u5e94\u7acb\u5373\u8054\u7cfb\u533b\u751f\u3002\u533b\u751f\u5f88\u53ef\u80fd\u4f1a\u505c\u6b62\u7ed9\u836f\uff0c\u7136\u540e\u51cf\u5c11\u5242\u91cf\uff0c\u4ee5\u5e2e\u52a9\u60a8\u907f\u514d\u526f\u4f5c\u7528\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u4f7f\u7528 Xospata \u6cbb\u7597\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u7684\u63a8\u8350\u5242\u91cf\u4e3a 120 \u6beb\u514b\u3002\u5982\u679c\u51fa\u73b0\u526f\u4f5c\u7528\uff0c\u53ef\u51cf\u81f3 80 \u6beb\u514b\u3002\u5982\u679c\u60a8\u9519\u8fc7\u4e00\u6b21\u670d\u836f\uff0c\u4e14\u4e0b\u6b21\u670d\u836f\u65f6\u95f4\u4ecd\u7ea6\u4e3a 12 \u5c0f\u65f6\uff0c\u8bf7\u7acb\u5373\u670d\u836f\u3002\u5982\u679c\u4e0b\u6b21\u670d\u836f\u65f6\u95f4\u5728 12 \u5c0f\u65f6\u5185\uff0c\u8bf7\u7b49\u5f85\u4e0b\u6b21\u670d\u836f\u300212 \u5c0f\u65f6\u5185\u4e0d\u5f97\u670d\u7528\u8d85\u8fc7\u4e00\u6b21\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u8bf7\u6ce8\u610f\uff0c\u6b64\u836f\u5728\u533b\u5b66\u4e0a\u88ab\u8bbe\u8ba1\u4e3a\u4e00\u79cd\u957f\u671f\u6cbb\u7597\u9009\u62e9\u3002\u53ea\u8981\u533b\u751f\u786e\u5b9a\u8be5\u836f\u7269\u5bf9\u60a8\u5b89\u5168\u4e14\u60a8\u6ca1\u6709\u51fa\u73b0\u4efb\u4f55\u526f\u4f5c\u7528\uff0c\u60a8\u5c31\u53ef\u4ee5\u957f\u671f\u4f7f\u7528 Xospata\u3002&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Side_Effects_of_Xospata\"><\/span>Xospata\u7684\u526f\u4f5c\u7528<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">\u4f7f\u7528Xospata\u53ef\u80fd\u4f1a\u5f15\u8d77\u4e00\u4e9b\u8f7b\u5fae\u6216\u4e25\u91cd\u7684\u526f\u4f5c\u7528\u3002\u8bf7\u6ce8\u610f\uff0c\u4ee5\u4e0b\u5217\u51fa\u7684\u526f\u4f5c\u7528\u5e76\u4e0d\u4ee3\u8868\u4f7f\u7528\u8be5\u836f\u7269\u53ef\u80fd\u51fa\u73b0\u7684\u6240\u6709\u53cd\u5e94\u3002&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">\u56e0\u6b64\uff0c\u4e0e\u60a8\u7684\u533b\u751f\u6216\u836f\u5242\u5e08\u4ea4\u8c08\u4ee5\u66f4\u597d\u5730\u4e86\u89e3\u4e0e\u4f7f\u7528\u8be5\u836f\u7269\u76f8\u5173\u7684\u6240\u6709\u526f\u4f5c\u7528\u975e\u5e38\u91cd\u8981\u3002&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mild_and_Common_Side_Effects\"><\/span>\u8f7b\u5fae\u548c\u5e38\u89c1\u7684\u526f\u4f5c\u7528<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">\u4f7f\u7528 Xospata \u65f6\u53ef\u80fd\u4f1a\u9047\u5230\u7684\u4e00\u4e9b\u5e38\u89c1\u526f\u4f5c\u7528\u5305\u62ec\uff1a<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">\u75b2\u52b3<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u5173\u8282\u548c\u808c\u8089\u75bc\u75db<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u4f4e\u8840\u538b<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u6d6e\u80bf<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u53d1\u70e7<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u8179\u6cfb<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u53e3\u8154\u6e83\u75a1\u6216\u80bf\u80c0<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u4fbf\u79d8<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u809d\u9176\u6c34\u5e73\u5347\u9ad8<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u76ae\u75b9<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u547c\u5438\u56f0\u96be<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u5934\u6655<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u5455\u5410&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u6076\u5fc3<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">\u8fd9\u4e9b\u526f\u4f5c\u7528\u88ab\u5f52\u7c7b\u4e3a\u8f7b\u5fae\u6216\u5e38\u89c1\uff0c\u56e0\u4e3a\u5b83\u4eec\u901a\u5e38\u4f1a\u5728\u51e0\u5929\u6216\u51e0\u5468\u540e\u6d88\u5931\u3002\u4f46\u662f\uff0c\u5982\u679c\u526f\u4f5c\u7528\u6301\u7eed\u5b58\u5728\u6216\u53d8\u5f97\u4e25\u91cd\uff0c\u60a8\u5e94\u8be5\u54a8\u8be2\u533b\u751f\u3002&nbsp;<\/span><\/p>\n\n\n\n<div  id=\"call-to-action-6ecd5e490506bf2fc7c4454343d8d1be\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u5411\u4e13\u5bb6\u54a8\u8be2\u526f\u4f5c\u7528\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Serious_Side_Effects\"><\/span>\u4e25\u91cd\u7684\u526f\u4f5c\u7528<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">\u4ee5\u4e0b\u526f\u4f5c\u7528\u5e76\u4e0d\u5e38\u89c1\uff0c\u51fa\u73b0\u8fd9\u4e9b\u526f\u4f5c\u7528\u540e\u5e94\u7acb\u5373\u5bfb\u6c42\u533b\u7597\u5e2e\u52a9\u6216\u62e8\u6253 911\uff1a<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">\u80f0\u817a\u708e<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u8111\u80bf\u80c0\uff0c\u4e5f\u79f0\u4e3a\u540e\u90e8\u53ef\u9006\u6027\u8111\u75c5\u7efc\u5408\u5f81<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u5fc3\u5f8b\u5f02\u5e38&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u7ec6\u80de\u5206\u5316\u662f\u6307\u7ec6\u80de\u53d1\u751f\u53d8\u5316\u5e76\u6570\u91cf\u589e\u52a0\u7684\u4e00\u79cd\u60c5\u51b5\u3002\u90e8\u5206\u75c7\u72b6\u5305\u62ec\u4f53\u91cd\u7a81\u7136\u589e\u52a0\u3001\u53d1\u70e7\u3001\u80be\u810f\u95ee\u9898\u8ff9\u8c61\u3001\u547c\u5438\u6025\u4fc3\u548c\u4f4e\u8840\u538b\u3002\u5982\u679c\u75c7\u72b6\u548c\u4f53\u5f81\u6301\u7eed\u5b58\u5728\uff0c\u533b\u751f\u53ef\u80fd\u4f1a\u6682\u505c\u670d\u7528Xospata\uff0c\u5e76\u5728\u75c7\u72b6\u548c\u4f53\u5f81\u6539\u5584\u540e\u6062\u590d\u670d\u7528\u3002&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span>\u6210\u672c<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">\u8d2d\u4e70 Xospata \u7684\u8d39\u7528\u53d6\u51b3\u4e8e\u8bb8\u591a\u56e0\u7d20\uff0c\u5305\u62ec\u60a8\u7684\u533b\u7597\u4fdd\u5065\u63d0\u4f9b\u8005\u3001\u60a8\u7684\u4fdd\u9669\u8ba1\u5212\u3001\u60a8\u4f7f\u7528\u7684\u836f\u623f\u4ee5\u53ca\u60a8\u7684\u6240\u5728\u5730\u3002\u7531\u4e8e\u8d39\u7528\u56e0\u4eba\u800c\u5f02\uff0c\u8bf7\u8054\u7cfb\u60a8\u7684\u836f\u623f\u4ee5\u83b7\u53d6\u6700\u65b0\u4ef7\u683c\u3002&nbsp;<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>\u764c\u75c7\u662f\u4e16\u754c\u4e0a\u6700\u81f4\u547d\u7684\u5065\u5eb7\u95ee\u9898\u4e4b\u4e00\u3002\u5b83\u6709\u591a\u79cd\u4e0d\u540c\u7684\u5f62\u5f0f\uff0c\u5176\u4e2d\u4e00\u79cd\u5c31\u662f\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5 (AML)\u3002AML \u662f\u4e00\u79cd\u8840\u764c\uff0c\u8d77\u6e90\u4e8e\u9aa8\u9ad3\u3002<\/p>","protected":false},"author":21,"featured_media":22216,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[13],"tags":[27],"class_list":["post-22214","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","tag-dr-abdelaziz-alsamarah"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Xospata (Gilteritinib) - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Xospata is a drug prescribed for the treatment of acute myeloid leukemia. Learn about the dosage, side effects, and efficacy of this drug.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xospata (Gilteritinib) - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Xospata is a drug prescribed for the treatment of acute myeloid leukemia. Learn about the dosage, side effects, and efficacy of this drug.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-29T19:50:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-09T22:28:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/\"},\"author\":{\"name\":\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#\\\/schema\\\/person\\\/2f73858b25c20aa6bf5b731fd4e593c4\"},\"headline\":\"Xospata (Gilteritinib)\",\"datePublished\":\"2022-12-29T19:50:54+00:00\",\"dateModified\":\"2024-07-09T22:28:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/\"},\"wordCount\":1085,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Xospata-Gilteritinib.jpg\",\"keywords\":[\"Dr. Abdelaziz Alsamarah\"],\"articleSection\":[\"Cancer\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/\",\"name\":\"Xospata (Gilteritinib) - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Xospata-Gilteritinib.jpg\",\"datePublished\":\"2022-12-29T19:50:54+00:00\",\"dateModified\":\"2024-07-09T22:28:18+00:00\",\"description\":\"Xospata is a drug prescribed for the treatment of acute myeloid leukemia. Learn about the dosage, side effects, and efficacy of this drug.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Xospata-Gilteritinib.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/Xospata-Gilteritinib.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Doctor diagnosing condition that is treated with Xospata\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/cancer\\\/xospata-gilteritinib\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xospata (Gilteritinib)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspe.wpenginepowered.com\\\/#\\\/schema\\\/person\\\/2f73858b25c20aa6bf5b731fd4e593c4\",\"name\":\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g\",\"caption\":\"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP\"},\"description\":\"Dr. Alsamarah received his PharmD degree from the University of Jordan in 2011. In pursuit of higher education, he joined Western University of Health Sciences, Pomona, CA in 2014 and received a masters in pharmaceutical sciences with major in Computer-Aided Drug Design (CADD). He has authored and co-authored several publications in major scientific journals. After graduation, Dr. Alsamarah worked in various pharmacy settings before he found his passion in managing patients on IV infusions. His specialty areas include: Infectious diseases, nutrition support, and monoclonal antibodies. In his free time, he likes boxing, biking, and painting with his three kids.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/author\\\/abdelaziz\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xospata\uff08Gilteritinib\uff09-AmeriPharma\u00ae \u4e13\u79d1\u62a4\u7406","description":"Xospata \u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u7684\u5904\u65b9\u836f\u3002\u4e86\u89e3\u8be5\u836f\u7684\u5242\u91cf\u3001\u526f\u4f5c\u7528\u548c\u7597\u6548\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/","og_locale":"zh_CN","og_type":"article","og_title":"Xospata (Gilteritinib) - AmeriPharma\u00ae Specialty Care","og_description":"Xospata is a drug prescribed for the treatment of acute myeloid leukemia. Learn about the dosage, side effects, and efficacy of this drug.","og_url":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2022-12-29T19:50:54+00:00","article_modified_time":"2024-07-09T22:28:18+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg","type":"image\/jpeg"}],"author":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","Est. reading time":"5 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/"},"author":{"name":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#\/schema\/person\/2f73858b25c20aa6bf5b731fd4e593c4"},"headline":"Xospata (Gilteritinib)","datePublished":"2022-12-29T19:50:54+00:00","dateModified":"2024-07-09T22:28:18+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/"},"wordCount":1085,"publisher":{"@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg","keywords":["Dr. Abdelaziz Alsamarah"],"articleSection":["Cancer"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/","name":"Xospata\uff08Gilteritinib\uff09-AmeriPharma\u00ae \u4e13\u79d1\u62a4\u7406","isPartOf":{"@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg","datePublished":"2022-12-29T19:50:54+00:00","dateModified":"2024-07-09T22:28:18+00:00","description":"Xospata \u662f\u4e00\u79cd\u7528\u4e8e\u6cbb\u7597\u6025\u6027\u9ad3\u7cfb\u767d\u8840\u75c5\u7684\u5904\u65b9\u836f\u3002\u4e86\u89e3\u8be5\u836f\u7684\u5242\u91cf\u3001\u526f\u4f5c\u7528\u548c\u7597\u6548\u3002","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg","width":1280,"height":853,"caption":"Doctor diagnosing condition that is treated with Xospata"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/xospata-gilteritinib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspe.wpenginepowered.com\/es\/"},{"@type":"ListItem","position":2,"name":"Xospata (Gilteritinib)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#website","url":"https:\/\/ameripharmaspe.wpenginepowered.com\/","name":"AmeriPharma\u00ae \u4e13\u4e1a\u62a4\u7406","description":"AmeriPharma \u7684\u4e13\u4e1a\u62a4\u7406","publisher":{"@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspe.wpenginepowered.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#organization","name":"\u7f8e\u56fd\u5236\u836f\u4e13\u4e1a\u62a4\u7406","url":"https:\/\/ameripharmaspe.wpenginepowered.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspe.wpenginepowered.com\/#\/schema\/person\/2f73858b25c20aa6bf5b731fd4e593c4","name":"Abdelaziz Alsamarah \u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb\uff0cMSPS\uff0cBCSCP","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8671a91ecba97f36a7f5e6492c279b433d2a9c2ac61cf480154cdd3c51b5fe3d?s=96&d=mm&r=g","caption":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP"},"description":"Alsamarah \u535a\u58eb\u4e8e 2011 \u5e74\u83b7\u5f97\u7ea6\u65e6\u5927\u5b66\u836f\u5b66\u535a\u58eb\u5b66\u4f4d\u3002\u4e3a\u4e86\u8ffd\u6c42\u66f4\u9ad8\u7684\u5b66\u4e1a\uff0c\u4ed6\u4e8e 2014 \u5e74\u52a0\u5165\u52a0\u5dde\u6ce2\u83ab\u7eb3\u5e02\u897f\u90e8\u5065\u5eb7\u79d1\u5b66\u5927\u5b66\uff0c\u5e76\u83b7\u5f97\u4e86\u836f\u5b66\u7855\u58eb\u5b66\u4f4d\uff0c\u4e3b\u4fee\u8ba1\u7b97\u673a\u8f85\u52a9\u836f\u7269\u8bbe\u8ba1 (CADD)\u3002\u4ed6\u66fe\u5728\u4e3b\u8981\u79d1\u5b66\u671f\u520a\u4e0a\u53d1\u8868\u8fc7\u591a\u7bc7\u8bba\u6587\uff0c\u5305\u62ec\u4e2a\u4eba\u548c\u5408\u8457\u3002\u6bd5\u4e1a\u540e\uff0cAlsamarah \u535a\u58eb\u66fe\u5728\u591a\u5bb6\u836f\u623f\u5de5\u4f5c\uff0c\u4e4b\u540e\u5bf9\u9759\u8109\u8f93\u6db2\u60a3\u8005\u7684\u7ba1\u7406\u4ea7\u751f\u4e86\u6d53\u539a\u7684\u5174\u8da3\u3002\u4ed6\u7684\u4e13\u4e1a\u9886\u57df\u5305\u62ec\uff1a\u4f20\u67d3\u75c5\u3001\u8425\u517b\u652f\u6301\u548c\u5355\u514b\u9686\u6297\u4f53\u3002\u95f2\u6687\u65f6\uff0c\u4ed6\u559c\u6b22\u548c\u4e09\u4e2a\u5b69\u5b50\u4e00\u8d77\u6253\u62f3\u51fb\u3001\u9a91\u81ea\u884c\u8f66\u548c\u753b\u753b\u3002","url":"https:\/\/ameripharmaspecialty.com\/zh\/author\/abdelaziz\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/abdelaziz\/"},"uagb_comment_info":1,"uagb_excerpt":"Cancer is one of the most deadly health issues in the world. It exists in many different forms, and one of these forms is acute myeloid leukemia (AML). AML is a type of blood cancer, and it originates from the bone marrow.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2022\/12\/Xospata-Gilteritinib.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Abdelaziz Alsamarah, PharmD, MSPS, BCSCP","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/abdelaziz\/"},"rttpg_comment":1,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/zh\/category\/cancer\/\" rel=\"category tag\">Cancer<\/a>","rttpg_excerpt":"Cancer is one of the most deadly health issues in the world. It exists in many different forms, and one of these forms is acute myeloid leukemia (AML). AML is a type of blood cancer, and it originates from the bone marrow.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/22214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/comments?post=22214"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/22214\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media\/22216"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media?parent=22214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/categories?post=22214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/tags?post=22214"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}